Prokidney (PROK) Total Liabilities (2021 - 2026)
Prokidney (PROK) reported Total Liabilities of $29.7 million for Q1 2026, down 17.75% year-over-year from $36.1 million in Q1 2025, and down 14.67% quarter-over-quarter from $34.8 million in Q4 2025.
Prokidney (PROK) Total Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Total Liabilities data on file, last reported at $29.7 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $29.7 million, down 17.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.7 million (down 17.75% YoY), and the FY2025 annual result was $34.8 million, down 11.8% from the prior year.
- Total Liabilities fell to $29.7 million in Q1 2026 per PROK's latest filing, from $34.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $39.4 million in Q4 2024 and troughed at $11.9 million in Q3 2022.
- A 5-year average of $25.7 million and a median of $27.3 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities surged 66264.83% in 2022, then dropped 17.75% in 2026.
- A 5-year view of Total Liabilities shows it stood at $13.1 million in 2022, then soared by 123.76% to $29.2 million in 2023, then jumped by 34.98% to $39.4 million in 2024, then declined by 11.8% to $34.8 million in 2025, then fell by 14.67% to $29.7 million in 2026.
- Business Quant data shows PROK's Total Liabilities at $29.7 million in Q1 2026, $34.8 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 29.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.68 Mn |
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 33.27 Mn |
| Jun 30, 2025 | 32.68 Mn |
| Mar 31, 2025 | 36.08 Mn |
| Dec 31, 2024 | 39.44 Mn |
| Sep 30, 2024 | 31.33 Mn |
| Jun 30, 2024 | 26.80 Mn |
| Mar 31, 2024 | 24.73 Mn |
| Dec 31, 2023 | 29.22 Mn |
| Sep 30, 2023 | 23.62 Mn |
| Jun 30, 2023 | 27.28 Mn |
| Mar 31, 2023 | 14.17 Mn |
| Dec 31, 2022 | 13.06 Mn |
| Sep 30, 2022 | 11.87 Mn |
| Jun 30, 2022 | 15.63 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | -15.26 Mn |